# The molecular workshop

> Reshaping the chain — Route 66 Peptides — At Route 66 Peptides, molecular hybrids and a constrained terminal region explain how researchers pursued oral growth-hormone secretagogues.

A road can be rerouted. Here, the object being rerouted also changes shape.

## Joining two designs

Researchers [combined structural features of NN703 and ipamorelin](https://pubmed.ncbi.nlm.nih.gov/11459660/) and tested the hybrids in rat pituitary cells and for growth-hormone release in swine. Reintroducing ipamorelin's C-terminal features into the NN703 design produced unexpectedly potent compounds in both settings. The C-terminus is one end of the molecular chain.

That reversal delights me. A design altered for oral access still had something to gain from features of its starting molecule. The result makes the chemistry feel less like a march toward one ideal structure and more like a workshop where discarded pieces return to the bench.

> The hybrid study tested hormone-releasing activity in cells and swine. Its finding concerns those compounds in those tests.

![Hands rearranging the end pieces of two large molecular teaching models on a sand-coloured table](images/hinged-chain-workshop.webp)

*A constructed teaching scene about molecular redesign; the oversized chain models are schematic.*

## Restricting the terminal shape

A [study of conformational restriction in the C-terminal region](https://pubmed.ncbi.nlm.nih.gov/12204475/) explored how limiting a compound's possible shapes affected potency. Derived compounds achieved activity in rat pituitary-cell tests, and the research reported 40% oral bioavailability with a growth-hormone response in swine.

That combination of findings appeals to my mechanical imagination: changing the freedom of one end of a chain can change how the whole compound behaves. I'd judge the reach of that principle from the measurements for each candidate. The study concerns a set of engineered secretagogues.

## Absorption, potency and selectivity

The [oral series studied in dogs](https://pubmed.ncbi.nlm.nih.gov/9733496/) and the [hybrid tests in cells and swine](https://pubmed.ncbi.nlm.nih.gov/11459660/) place different demands on a candidate. Passing into blood, stimulating growth-hormone release and retaining a desirable hormonal profile each require measurements of their own.

I give the chemists credit for working on several constraints at once. The next stop, [hormone selectivity](/hormone-selectivity), is where the attractive word selective becomes more demanding than a family resemblance.

---

Route 66 Peptides is my roadside notebook of published research, an editorial project with no sales or medical advice.